Kronos Bio, Inc.
KRON · NASDAQ
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Market Cap | $50,166 | $57,327 | $60,306 | $67,312 |
| - Cash | $91,577 | $84,571 | $74,964 | $70,207 |
| + Debt | $24,089 | $24,900 | $25,798 | $27,132 |
| Enterprise Value | -$17,322 | -$2,344 | $11,140 | $24,237 |
| Revenue | $1,864 | $2,270 | $2,370 | $2,688 |
| % Growth | -17.9% | -4.2% | -11.8% | – |
| Gross Profit | $1,516 | $2,270 | $2,370 | $2,688 |
| % Margin | 81.3% | 100% | 100% | 100% |
| EBITDA | -$6,154 | -$10,654 | -$15,304 | -$17,025 |
| % Margin | -330.2% | -469.3% | -645.7% | -633.4% |
| Net Income | -$8,364 | -$25,813 | -$14,108 | -$16,200 |
| % Margin | -448.7% | -1,137.1% | -595.3% | -602.7% |
| EPS Diluted | -0.14 | -0.43 | -0.23 | -0.27 |
| % Growth | 67.4% | -87% | 14.8% | – |
| Operating Cash Flow | -$12,842 | -$12,835 | -$12,371 | -$16,330 |
| Capital Expenditures | $0 | -$4 | $7 | $0 |
| Free Cash Flow | -$12,842 | -$12,839 | -$12,364 | -$16,330 |